Johnson & Johnson faces $2 billion lawsuit over opioids [CBS News]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: CBS News
New York state is suing Johnson & Johnson and looking to recover $2 billion over the pharmaceutical giant's alleged role in the opioid epidemic, which has left millions of Americans addicted to the potent painkillers, and hundreds of thousands dead.A division of J&J poured millions of dollars into marketing opioids and downplaying the risks, according to thelawsuit"The opioid crisis has taken too many lives and New York State will continue to take action against those who helped fuel this public health catastrophe and bring a measure of justice to families who have lost loved ones," New York Governor Andrew Cuomo said astatementOklahoma AG on major opioid win 05:31Johnson & Johnson did not respond to a request for comment.Get Breaking Delivered to Your InboxThe company has faced considerable litigation in other states related to opioid abuse. Last year, an Oklahoma judge ordered the drugmaker topay nearly $500 millionIn contrast, New York is not suing J&J direc
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Antispasmodics Drugs: Global Market Analysis and Forecast 2018-2033 Featuring Daiichi Sankyo Company, Fresenius Kabi, Hikma Pharma, Johnson & Johnson Services, Pfizer, and Other Key Players [Yahoo! Finance]Yahoo! Finance
- Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development [Yahoo! Finance]Yahoo! Finance
- Artificial Joints Market to Reach $32.57 Billion by 2033; Rising Prevalence of Sedentary Lifestyle to Propel Growth [Yahoo! Finance]Yahoo! Finance
- Ethereum price today: ETH is trading at $3,179.50 [USA TODAY]USA TODAY
- AMSilk strengthens management team with key hires of Ralph Fraundorfer and Ctibor Kohutovic to Management Board [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 4/16/24 - Form 8-K/A
- 4/16/24 - Form 8-K
- 3/27/24 - Form PX14A6G
- JNJ's page on the SEC website